ARCH Venture Partners X, LLC

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$52.3M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of ARCH Venture Partners X, LLC

According to the SEC Form 4 filings, ARCH Venture Partners X, LLC, being in a position of

  1. 10 percent owner at Prime Medicine, Inc.,
    оver the last 12 months, has bought 3200000 shares for $20M, and sold 0 shares,
    over all time since 2022-10-24, has bought 3600000 shares for $26.8M, and sold 0 shares.

The largest purchase of all time was on 2023-09-19 and amounted to 1500000 shares of Neumora Therapeutics, Inc. Common Stock for $25.5M.

Biography of ARCH Venture Partners X, LLC

No biography is available at this moment.

2024-02-15PurchasePrime Medicine, Inc.
PRME
10 percent owner
3.2M
4.6348%
$6.25$20M-36.86%
2023-09-19PurchaseNeumora Therapeutics, Inc. Common Stock
NMRA
10 percent owner
1.5M
1.5879%
$17.00$25.5M-1.04%
2022-10-24PurchasePrime Medicine, Inc.
PRME
director
400,000
1.5758%
$17.00$6.8M-3.68%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.